
Results 1 - 11 of 11 in Wyeth
Abbott Wins Ruling in Xience Stent Case Over J&J, Wyeth
Abbott Laboratories and Medtronic Inc. won a federal court ruling that invalidated two patents for heart devices controlled by Johnson & Johnson 's Cordis unit and Wyeth . Comment?
Holden Looks Back at 13 Years in Borough Government
... was a big deal, the same thing with keeping Pfizer in Madison. Right after Pfizer's acquisition of [Madison-based] Wyeth [in 2009], we put on a full-court press. Pfizer, with 1,200 employees, is the largest employer in town and will be even after ... Comment?
EKR Therapeutics Names Two Independent Directors and Reaffirms Board...
... Pharmaceuticals, and Marion Laboratories. Mr. Mahady joins the EKR Board after an illustrious career at Wyeth, a Fortune 110 pharma/biotech company. During his 30+ year tenure there, Joe served as President of various business units, culminating as ... Comment?
Intellect Neurosciences, Inc. Files Appeal in Europe in Response to...
Intellect Neurosciences, Inc. Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth / Pfizer Inc. Comment?
CEO of PPD resigns, effective immediately
... director of The Carlyle Group; Allen Thorpe, managing director of Hellman & Friedman; and Bob Essner, former CEO of Wyeth Pharmaceuticals. Additionally, the Office of the Chairman has also established an Executive Committee that will have ... Comment?
Joseph M. Mahady Joins Albemarle Board of Directors
... leadership make him an ideal fit for our already strong and diverse board of directors." In 2009, Mahady retired from Wyeth Corporation, a global manufacturer of pharmaceutical products, following its acquisition by Pfizer and after 30 years with ... Comment?
Jury awards 3 women $72M for cancer caused by Prempro
... take two weeks to determine punitive damages. The three women who sued over the drug live or lived in Pennsylvania. Wyeth Pharmaceuticals (WYE) was hit with dozens of lawsuits after a study found Prempro users had a much higher incidence of breast ... Comment?
Merck hires new animal health unit president
... starting Sept. 15. Kohan will stay with Merck through the end of 2011 and then retire. DeLuca, 48, was president of Wyeth's animal health unit until from 2007 to 2010. He has been the chief financial officer of Becton Dickinson's Bioscience business ... Comment?
Pfizer After Lipitor Slims Down to Focus on Mini-Blockbusters
... in New York, in a note to clients. The drugs are Prevnar, a bacterial infection vaccine gained in Pfizer's 2009 Wyeth purchase; the blood-thinner Eliquis, co- developed with Bristol-Myers Squibb Co. (BMY) ; the rheumatoid arthritis drug tofacitinib; ... Comment?
... antitrust lawsuit Thursday, seeking class-action status in U.S. District Court in Trenton against pharmaceutical giant Wyeth Inc., which is based in Madison. The 79-page complaint contends that Wyeth used "sham litigation" to delay marketing of a ... Comment?
Fitch Downgrades Pfizer, Inc.'s IDR to 'A+'; Outlook Stable
Pfizer has shown some financial discipline by reducing the debt load that nearly tripled with the $68 billion acquisition of Wyeth in October 2009. Comment?